Patents Examined by L. Channavajjala
  • Formulations and methods for reducing skin irritation
    Patent number: 6139850
    Abstract: Composition and methods are provided for inhibiting skin irritation attributable to chemical irritants or environmental conditions, by the application of an anti-irritant amount of aqueous-soluble strontium cation.
    Type: Grant
    Filed: June 23, 1997
    Date of Patent: October 31, 2000
    Assignee: Cosmederm Technologies
    Inventors: Gary S. Hahn, David O. Thueson
  • S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
    Patent number: 6033682
    Abstract: The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions responsive to selegiline include those produced by neuronal degeneration or neuronal trauma and those due to immune system dysfunction. Effective dosages are a daily dose of at least about 0.015 mg/kg of body weight.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: March 7, 2000
    Assignee: Somerset Pharmaceuticals, Inc.
    Inventor: Anthony R. DiSanto
  • Polymer composition for delivering substances in living organisms
    Patent number: 6030941
    Abstract: Polymeric compositions effective for delivering compounds in living organisms are described. The compositions include polypeptides which exhibit solubility in both hydrophilic and lipophilic environments by undergoing a reversible pH-dependent transition from a low-pH, lipophilic form to a high-pH, hydrophilic form.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: February 29, 2000
    Assignee: AVI BioPharma, Inc.
    Inventors: James E. Summerton, Dwight D. Weller
  • Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
    Patent number: 6004581
    Abstract: Modified release pharmaceutical composition and method for the treatment of inflammatory bowel diseases (IBD) such as Crohn's disease and Colitis Ulccrosa, said compositions comprising as active the ingredient 5-aminosalicylic acid (5-ASA), and being adapted for modified and targeted release so as to obtain a clinically important localized effect profile of 5-ASA by means of releasing an appropriate amount of 5-ASA in both the small and large bowel.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: December 21, 1999
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventors: Svenn Kluver Jepsen, S.o slashed.ren Halskov
  • Bone graft composites and spacers
    Patent number: 5972368
    Abstract: A bone graft substitute including a composition of natural selectively deactivated bone material which has been processed to remove associated non-collagenous bone proteins, said bone material containing native collagen materials and naturally associated bone minerals and substantially free from native non-collagenous protein, and a therapeutically effective amount to stimulate bone growth of a bone growth factor in a pharmaceutically acceptable carrier in synergistic combination with said bone material. Spacers composed of the bone graft substitute composition methods for using the spacers are also provided.
    Type: Grant
    Filed: June 11, 1997
    Date of Patent: October 26, 1999
    Assignee: SDGI Holdings, Inc.
    Inventor: William F. McKay
  • Method for the treatment of dry skin
    Patent number: 5951989
    Abstract: A method for the treatment of dry skin by applying an effective amount of thyroid hormone in a pharmaceutically acceptable carrier to the skin.
    Type: Grant
    Filed: April 7, 1997
    Date of Patent: September 14, 1999
    Inventor: Warren R. Heymann